Literature DB >> 1863822

Role of TNF alpha, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage.

B Wilbrink1, J J Nietfeld, W den Otter, J L van Roy, J W Bijlsma, O Huber-Bruning.   

Abstract

In both young and old human articular cartilage explants, TNF alpha induced a concentration-dependent, reversible suppression of the proteoglycan (PG) synthesis. Young cartilage was more sensitive to TNF alpha than old cartilage: 50% suppression of PG synthesis was reached at a TNF alpha concentration of 5 U/ml for young and 30 U/ml for old cartilage, whereas at 10(3) U/ml the PG synthesis of young cartilage was blocked and that of old cartilage suppressed by 80%. These inhibition levels of PG synthesis resulted in 25% PG depletion of the explants after 8 days of culture. The release of cartilage PG was not enhanced. TNF alpha induced no detectable amounts of IL-1 (less than 0.01 U) in young or old cartilage but did induce IL-6 production. The induced amounts of IL-6 were higher in young than in old cartilage but no dose-dependency was evident. Antibodies to neither IL-1 nor IL-6 had any influence on the TNF alpha-induced suppression of PG synthesis. The combination of TNF alpha and IL-1 led to an additive inhibition of PG synthesis which had no relationship to induced IL-6. TNF alpha was about 100-fold less active than IL-1.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1863822     DOI: 10.1093/rheumatology/30.4.265

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  11 in total

1.  Serum levels of TNF-α, IL-1β, COMP, and CTX-II in patients with Kashin-Beck disease in Sichuan, China.

Authors:  Xin Tang; Zongke Zhou; Bin Shen; Jing Yang; Pengde Kang; Jian Li; Nicolas Crook; Qi Li; Li Min; Fuxing Pei
Journal:  Rheumatol Int       Date:  2011-11-09       Impact factor: 2.631

2.  Degradation of human cartilage by cytokines in vitro.

Authors:  J J Nietfeld; B Wilbrink; O Huber-Bruning; J W Bijlsma; J J Nietfeld; W Den Otter
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

Review 3.  Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes.

Authors:  P J Verschure; C J Van Noorden; J Van Marle; W B Van den Berg
Journal:  Histochem J       Date:  1996-12

Review 4.  Cytokines and proteoglycans.

Authors:  J J Nietfeld
Journal:  Experientia       Date:  1993-05-15

5.  Coculture of human articular chondrocytes with peripheral blood mononuclear cells as a model to study cytokine-mediated interactions between inflammatory cells and target cells in the rheumatoid joint.

Authors:  A M Malfait; G Verbruggen; K F Almqvist; C Broddelez; E M Veys
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-11       Impact factor: 2.416

6.  Moderate dynamic compression inhibits pro-catabolic response of cartilage to mechanical injury, tumor necrosis factor-α and interleukin-6, but accentuates degradation above a strain threshold.

Authors:  Y Li; E H Frank; Y Wang; S Chubinskaya; H-H Huang; A J Grodzinsky
Journal:  Osteoarthritis Cartilage       Date:  2013-09-03       Impact factor: 6.576

7.  Short-term exposure of cartilage to blood results in chondrocyte apoptosis.

Authors:  Michel Hooiveld; Goris Roosendaal; Marion Wenting; Marijke van den Berg; Johannes Bijlsma; Floris Lafeber
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

8.  Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4.

Authors:  J A van Roon; J L van Roy; A Duits; F P Lafeber; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

9.  Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells.

Authors:  Leonie S Taams; Jocea M R van Amelsfort; Machteld M Tiemessen; Kim M G Jacobs; Esther C de Jong; Arne N Akbar; Johannes W J Bijlsma; Floris P J G Lafeber
Journal:  Hum Immunol       Date:  2005-03       Impact factor: 2.850

Review 10.  Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis.

Authors:  Manon C Zweers; Tineke N de Boer; Joël van Roon; Johannes W J Bijlsma; Floris P J G Lafeber; Simon C Mastbergen
Journal:  Arthritis Res Ther       Date:  2011-09-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.